Lucid Diagnostics, Inc.
5 clinical trials · Sponsor
◉ Watch Lucid Diagnostics, Inc.
| Record | Firm | Date |
|---|---|---|
| Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population (NCT05778851) | Lucid Diagnostics, Inc. | 2023-04-12 |
| Lucid Registry Study (NCT05965999) | Lucid Diagnostics, Inc. | 2023-04-11 |
| CLUE: CLinical Utility Study of EsoGuard (NCT06030180) | Lucid Diagnostics, Inc. | 2023-02-23 |
| Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC (NCT04295811) | Lucid Diagnostics, Inc. | 2020-06-18 |
| Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE (NCT04293458) | Lucid Diagnostics, Inc. | 2020-02-28 |
Track Lucid Diagnostics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.